17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Critical Neurotransmitters in the Neuroimmune Network

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Immune cells rely on cell-cell communication to specify and fine-tune their responses. They express an extensive network of cell communication modes, including a vast repertoire of cell surface and transmembrane receptors and ligands, membrane vesicles, junctions, ligand and voltage-gated ion channels, and transporters. During a crosstalk between the nervous system and the immune system these modes of cellular communication and the downstream signal transduction events are influenced by neurotransmitters present in the local tissue environments in an autocrine or paracrine fashion. Neurotransmitters thus influence innate and adaptive immune responses. In addition, immune cells send signals to the brain through cytokines, and are present in the brain to influence neural responses. Altered communication between the nervous and immune systems is emerging as a common feature in neurodegenerative and immunopathological diseases. Here, we present the mechanistic frameworks of immunostimulatory and immunosuppressive effects critical neurotransmitters — dopamine (3,4-dihydroxyphenethylamine), serotonin (5-hydroxytryptamine), substance P (trifluoroacetate salt powder), and L-glutamate — exert on lymphocytes and non-lymphoid immune cells. Furthermore, we discuss the possible roles neurotransmitter-driven neuroimmune networks play in the pathogenesis of neurodegenerative disorders, autoimmune diseases, cancer, and outline potential clinical implications of balancing neuroimmune crosstalk by therapeutic modulation.

          Related collections

          Most cited references252

          • Record: found
          • Abstract: found
          • Article: not found

          The role of inflammation in depression: from evolutionary imperative to modern treatment target.

          Crosstalk between inflammatory pathways and neurocircuits in the brain can lead to behavioural responses, such as avoidance and alarm, that are likely to have provided early humans with an evolutionary advantage in their interactions with pathogens and predators. However, in modern times, such interactions between inflammation and the brain appear to drive the development of depression and may contribute to non-responsiveness to current antidepressant therapies. Recent data have elucidated the mechanisms by which the innate and adaptive immune systems interact with neurotransmitters and neurocircuits to influence the risk for depression. Here, we detail our current understanding of these pathways and discuss the therapeutic potential of targeting the immune system to treat depression.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation.

            Excessive inflammation and tumour-necrosis factor (TNF) synthesis cause morbidity and mortality in diverse human diseases including endotoxaemia, sepsis, rheumatoid arthritis and inflammatory bowel disease. Highly conserved, endogenous mechanisms normally regulate the magnitude of innate immune responses and prevent excessive inflammation. The nervous system, through the vagus nerve, can inhibit significantly and rapidly the release of macrophage TNF, and attenuate systemic inflammatory responses. This physiological mechanism, termed the 'cholinergic anti-inflammatory pathway' has major implications in immunology and in therapeutics; however, the identity of the essential macrophage acetylcholine-mediated (cholinergic) receptor that responds to vagus nerve signals was previously unknown. Here we report that the nicotinic acetylcholine receptor alpha7 subunit is required for acetylcholine inhibition of macrophage TNF release. Electrical stimulation of the vagus nerve inhibits TNF synthesis in wild-type mice, but fails to inhibit TNF synthesis in alpha7-deficient mice. Thus, the nicotinic acetylcholine receptor alpha7 subunit is essential for inhibiting cytokine synthesis by the cholinergic anti-inflammatory pathway.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Tissue-Resident Macrophage Ontogeny and Homeostasis.

              Defining the origins and developmental pathways of tissue-resident macrophages should help refine our understanding of the role of these cells in various disease settings and enable the design of novel macrophage-targeted therapies. In recent years the long-held belief that macrophage populations in the adult are continuously replenished by monocytes from the bone marrow (BM) has been overturned with the advent of new techniques to dissect cellular ontogeny. The new paradigm suggests that several tissue-resident macrophage populations are seeded during waves of embryonic hematopoiesis and self-maintain independently of BM contribution during adulthood. However, the exact nature of the embryonic progenitors that give rise to adult tissue-resident macrophages is still debated, and the mechanisms enabling macrophage population maintenance in the adult are undefined. Here, we review the emergence of these concepts and discuss current controversies and future directions in macrophage biology.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Immunol
                Front Immunol
                Front. Immunol.
                Frontiers in Immunology
                Frontiers Media S.A.
                1664-3224
                21 August 2020
                2020
                : 11
                : 1869
                Affiliations
                [1] 1Department of Biochemistry, Cancer Biology, Neuroscience and Pharmacology, Meharry Medical College School of Medicine , Nashville, TN, United States
                [2] 2Department of Microbiology and Immunology, Meharry Medical College School of Medicine , Nashville, TN, United States
                [3] 3School of Graduate Studies and Research, Meharry Medical College , Nashville, TN, United States
                [4] 4Host-Tumor Interactions Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center , Nashville, TN, United States
                [5] 5Vanderbilt Center for Immunobiology, Vanderbilt University Medical Center , Nashville, TN, United States
                [6] 6Vanderbilt Institute for Infection, Immunology and Inflammation, Vanderbilt University Medical Center , Nashville, TN, United States
                Author notes

                Edited by: Francisco Sanchez-Madrid, Autonomous University of Madrid, Spain

                Reviewed by: Alberto Pascual, Institute of Biomedicine of Seville (IBIS), Spain; Derya Unutmaz, Jackson Laboratory for Genomic Medicine, United States; Cristina Gutierrez-Vazquez, Brigham and Women's Hospital and Harvard Medical School, United States

                *Correspondence: Anil Shanker ashanker@ 123456mmc.edu

                This article was submitted to T Cell Biology, a section of the journal Frontiers in Immunology

                †These authors have contributed equally to this work

                Article
                10.3389/fimmu.2020.01869
                7472989
                32973771
                82331cdf-beea-46e7-9aaf-36249891c560
                Copyright © 2020 Hodo, de Aquino, Shimamoto and Shanker.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 31 December 2019
                : 13 July 2020
                Page count
                Figures: 5, Tables: 4, Equations: 0, References: 298, Pages: 26, Words: 21301
                Funding
                Funded by: National Institutes of Health 10.13039/100000002
                Award ID: U54 CA163069
                Award ID: U54 MD007593
                Award ID: SC1 CA182843
                Award ID: SC1 CA182843-07S1
                Award ID: R01 CA175370
                Award ID: T32 5T32HL007737
                Categories
                Immunology
                Review

                Immunology
                t cell neuroimmunology,dopamine,glutamate,serotonin,substance p,cancer,neurodegenerative disorders,immunotherapy

                Comments

                Comment on this article